Abstract
The graded shield technique was developed to increase the sentinel node detection rate by improving lymphoscintigraphic image contrast. In a 6‐month period, 50 women with clinical suspicion of early stage breast cancer (T1 and T2 tumors) were enrolled in this study. The patients had a mean age of 47.2 ± 10.3 years. A composite graded shield was constructed using three concentric layers of leaded plastic measuring 3 cm, 5 cm, and 7 cm each in diameter. The graded shield was designed with a movable Velcro backing for accurate positioning over the injection site. Images were acquired with a vertical angle dual‐head gamma camera using an established injection procedure developed at our institution. The rate of detection of sentinel lymph nodes using lymphoscintigraphic mapping improved from 74% (37/50 patients) to 96% (48/50) using the graded shield (p < 0.05). In addition to the increased detection rate, our technique also increased the number of nodes detected and improved visualization of the adjacent lymphatic basin. By enhancing nodal contrast, we have demonstrated that the graded shield technique is an effective method for improving the rate of sentinel node detection.
Keywords: sentinel lymph node, breast cancer, graded shield
Full Text
The Full Text of this article is available as a PDF (175.4 KB).
References
- 1. Krag D, Weaver D, Ashikaga T, et al. The sentinel nodes in breast cancer. A multicenter validation study. N Engl J Med. 1998; 339: 941–946. [DOI] [PubMed] [Google Scholar]
- 2. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in patients with breast cancer. JAMA. 1996; 276: 1818–1822. [PubMed] [Google Scholar]
- 3. Mariani G, Moresco L, Viale G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med. 2001; 42: 1198–1215. [PubMed] [Google Scholar]
- 4. Cox CE, Salud CJ, Harrinton MA. The role of selective sentinel lymph node dissection in breast cancer. Surg Clin North Am. 2000; 80: 1759–1776. [DOI] [PubMed] [Google Scholar]
- 5. Noguchi M. Sentinel lymph node biopsy and breast cancer. Br J Surg. 2002; 89: 21–34. [DOI] [PubMed] [Google Scholar]
- 6. Alazraki NP, Styblo T, Grant SF, et al. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma‐detecting probe. Semin Nucl Med. 2000; 30: 56–64. [DOI] [PubMed] [Google Scholar]
- 7. Uren RF, Howman‐Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med. 1995; 36: 1775–1780. [PubMed] [Google Scholar]
- 8. Eshima D, Fauconnier T, Eshima L, Thornback JR. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. Semin Nucl Med. 2000; 30: 25–32. [DOI] [PubMed] [Google Scholar]
- 9. Leong SP, Morita ET, Treseler PA, Wong JH. Multidisciplinary approach to selective sentinel lymph node mapping in breast cancer. Breast Cancer. 2000; 7: 105–113. [DOI] [PubMed] [Google Scholar]
- 10. McMasters KM, Wong SL, Martin RC 2nd, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg. 2001; 233: 676–687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium‐99m‐colloidal albumin in breast cancer. J Nucl Med. 1997; 38: 366–368. [PubMed] [Google Scholar]
- 12. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 1998; 186: 275–283. [DOI] [PubMed] [Google Scholar]
- 13. Howarth DM, Forstrom LA, O'Connor MK, et al. Patient‐related pitfalls and artifacts in nuclear medicine imaging. Semin Nucl Med. 1996; 26: 295–307. [DOI] [PubMed] [Google Scholar]